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Abstract
The brain contains numerous mononuclear phagocytes called microglia. These cells express the transmembrane tyrosine
kinase receptor for the macrophage growth factor colony stimulating factor-1 (CSF-1R). Using a CSF-1R-GFP reporter mouse
strain combined with lineage defining antibody staining we show in the postnatal mouse brain that CSF-1R is expressed
only in microglia and not neurons, astrocytes or glial cells. To study CSF-1R function we used mice homozygous for a null
mutation in the Csflr gene. In these mice microglia are.99% depleted at embryonic day 16 and day 1 post-partum brain. At
three weeks of age this microglial depletion continues in most regions of the brain although some contain clusters of
rounded microglia. Despite the loss of microglia, embryonic brain development appears normal but during the post-natal
period the brain architecture becomes perturbed with enlarged ventricles and regionally compressed parenchyma,
phenotypes most prominent in the olfactory bulb and cortex. In the cortex there is increased neuronal density, elevated
numbers of astrocytes but reduced numbers of oligodendrocytes. Csf1r nulls rarely survive to adulthood and therefore to
study the role of CSF-1R in olfaction we used the viable null mutants in the Csf1 (Csf1op) gene that encodes one of the two
known CSF-1R ligands. Food-finding experiments indicate that olfactory capacity is significantly impaired in the absence of
CSF-1. CSF-1R is therefore required for the development of microglia, for a fully functional olfactory system and the
maintenance of normal brain structure.
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Introduction
The mammalian brain is populated with a large number of
mononuclear phagocytes known as microglia [1,2]. These cells are
found throughout the entire central nervous system at varying
densities and with a wide range of morphologies [3]. Microglia/
macrophages are found in the neural plate as soon as it is formed
[4] but in mice the major increase in microglial number occurs
postnatally from post-partum (PP) day 6 [5]. Microglia have been
ascribed many roles most frequently relating to immunological,
apoptotic cell clearance and repair activities [2,6,7,8]. It has also
been suggested that they have a role in neuronal development by
guiding axons [9] and eliminating neuronal projections [10]. For
example, in neuroendocrine neurons they have been shown to
‘‘prune’’ neurosecretory termini [11]. In addition, roles in
neurogenesis [11,12,13] and in neuronal survival and synapto-
genesis [14,15] have been proposed.
Macrophages are primarily regulated by the growth factor,
colony stimulating factor-1 (CSF-1, also known as macrophage-
CSF) [16]. CSF-1 signals via a Class III transmembrane receptor
tyrosine kinase (CSF-1R), the product of the cfms proto-oncogene
[17]. The central role of CSF-1 in macrophage biology was
demonstrated in vivo by genetic studies of mice homozygous for
the Csf1 null mutation osteopetrotic (Csf1op/op) [18] and Csflr null
mutation [19] as well as toothless (Tl) in rats that also lack CSF-1
[20]. In particular evaluation of Csf1op/op mice showed that the
majority of macrophages in the body are lost and many
macrophage populations, including those of bone, kidney, testis,
and dermis, are almost entirely absent [21]. However, despite the
universal expression of the CSF-1 receptor in macrophages, there
are some other populations of macrophages that show only small
or no alterations in their density through life such as the
Langerhans cells in the skin, the resident macrophages in the
lung [21,22] and the microglia in the brain [5,23]. Thus these
macrophages are not reliant on CSF-1 for their development,
survival and location. However, even in these cases where
macrophages are present in relatively normal numbers their
function is compromised in the absence of CSF-1, indicating the
need for CSF-1R signaling [24].
Targeted ablation of the Csf1r gene in mice also severely
depletes macrophage populations. Studies of these mice confirmed
that the CSF-1R is the only receptor for CSF-1, as all the
phenotypes of the CSF-1 null mutant were found in the receptor
null. However, Csf1r2/2 mice have an even more severe
PLoS ONE | www.plosone.org 1 October 2011 | Volume 6 | Issue 10 | e26317
phenotype than the Csf1 null and exhibit poorer viability [19]. The
Csf1r2/2 mice have also lost some mononuclear phagocytic
populations such as the Langerhans cells that are found in the Csf1
null [25]. These data suggest another ligand for this receptor.
Recently IL-34, was identified and shown to bind to the CSF-1R
receptor with high affinity and that can regulate myeloid
development and substitute for CSF-1 in vivo [26,27]. IL-34 has
overlapping but not identical biological activities as CSF-1 [28]
but shows different spatial and temporal expression patterns [27].
It is likely that this differential expression of IL-34 and CSF-1 can
explain the discrepancies in phenotypes between the Csf1op/op and
Csf1r2/2 mice and may explain the differential deletion of some
macrophage populations in the CSF-1 ligand and receptor null
mutants.
A characteristic of Csf1op/op and Csf1r2/2 mice is perturbation in
development in a wide range of tissues ranging from bone,
mammary gland to pancreas [19,29,30,31], suggesting important
roles for macrophages in development [32]. In the brain the sex
steroid hormone feedback control in the hypothalamus is
suppressed and this compromises the hypothalamic-pituitary-
gondal (HPG) system and affects reproductive capacity in both
sexes [33,34]. In addition intra-cortical electrophysiological
recordings of visual evoked potentials (VEP) that showed that
Csf1op/op mice have primary neuronal abnormalities [14]. These
data suggest that CSF-1 plays a role in the development of
neuronal circuitry and its absence results in a loss of appropriate
connectivity and deficits. However, on a gross histological level
Csf1op/op brains are normal and many behavioral features such as
balance and motor functions also appear normal [14]. CSF-1 thus
appears to affect specific pathways that result in appropriate
neuronal connectivity. As microglia are the primary expresser of
CSF-1R in the brain [35,36,37], the most parsimonious hypothesis
to explain these neuronal defects is that CSF-1 acts through
microglia to provide trophic factors to neurons during develop-
ment. Consistent with this hypothesis, in Csf1op/op mice fewer
microglia are recruited to the sites of injury in the brain and
neuronal survival is compromised relative to WT mice receiving
comparable injuries [38]. However, CSF-1R expression has also
been reported in neurons following ischemic shock, suggesting that
these cells might be direct CSF-1 targets at least during injury [38].
The observation that Csf1r null mutation causes more severe
phenotypes compared to the Csf1 null also suggests a redundancy
with IL-34 as described above. Thus to further study the role of
CSF-1R in the brain we employed genetic approaches. For this we
used null mutations in the Csf1r gene [39], a CSF-1R GFP
reporter mouse strain that has been shown to identify all
mononuclear phagocytes [40] and the originally described CSF-
1 ligand null mutant (Csf1op/op) [18]. In this report we show that
CSF-1R is expressed solely on microglia post-natally and its loss
results in a severe depletion of microglia in embryonic to post-
weaning mice. CSF-1R is also required for the maintenance of
normal brain architecture. In addition we demonstrate that CSF-1
signaling is essential for normal olfaction.
Results
Microglia are Strongly Reduced in Csf1r Null Mutant Mice
Microglial numbers plateau within three weeks of birth with all
brain regions populated to a varying extent and by cells with
differing morphologies [5]. Therefore, we compared mice
homozygous for the null mutation in the CSF-1 receptor
(Csf1r2/2) gene to littermate WT mice at 21 PP for the presence
of microglia using antibodies against the canonical microglial
markers, F4/80 and Iba1. This age was also chosen because the
Csf1r2/2 mutants on this genetic background rarely live beyond
this age with only occasional mice surviving until 5–6 weeks of age.
The mice selected for study were still active and not moribund.
Immunostaining with both anti-Iba1 and anti-F4/80 (data not
shown) antibodies detected microglia in sections of WT brains
(Figure 1A, B). These cells showed characteristic microglial
morphology [41] with varying degrees of ramification in all brain
areas analyzed (Fig. 1A a,c,e; 1B a,c,) and this pattern was evident
with both antibodies. In contrast, microglia in the Csf1r2/2 mice
as defined by Iba1 and F4/80 were significantly depleted at 21 PP
in all regions analyzed (Fig. 1Ab,d,f, Fig. 1Ba,c).
We performed automated unbiased enumeration of Iba1
expressing cells from different brain regions (Table 1). Iba1
labeled microglia were abundantly found in all regions of the WT
mice at varying densities (Table 1). However, consistent with
morphological analysis these counts showed that the Csf1r2/2
mice were significantly depleted in Iba1+ cells compared to WT.
Indeed in all brain regions of the mutant, most microscopic fields
were devoid of microglia indicating severe consequences resulting
from CSF-1R loss. However in some regions examined such as the
piriform cortex, hippocampus, thalamus and dentate gyrus
particularly from two out of the eight mutant mice examined,
there were some areas containing clusters of Iba1+ cells (Fig. 1B
b,d; Table 1). These bimodial distribution of cell counts are best
expressed as medians and this data shows the depletion of Iba1
positive cells in the mutant ranging from 99% in thalamus and
hypothalamus to ,65% in the least affected piriform cortex
(Table 1). In each area the difference in Iba1+ cells between WT
and Csf1r2/2 was highly significant. Overall when pooled counts
from all sections from all areas of the brain were pooled the overall
depletion of Iba1+ cells in the brains of Csf1r2/2mice was ,94%.
Importantly, even the remaining Iba1+ cells in Csf1r2/2 mutants
were all phenotypically different from normal WT microglia.
Visually (Fig. 1B b,d) and by quantitative morphometry [circular-
ity values of 0.83 (mutant) and 0.73 (WT); p,0.0001; see Methods
and Materials) mutant cells were more rounded and relatively
lacked the processes seen in the mature normal ramified microglia
of WT mice (Fig. 1Ba,c).
To determine when this depletion occurred we also examined
brains for macrophage/monocyte staining at embryonic day (E)16
(Iba1) and 1day PP (F4/80 and Iba1). In WT mice at E16, Iba1
positive cells were detected in the developing brain (Fig. 1A g).
However, no labeled cells were detected in the mutant embryonic
brains at this stage (Fig. 1Ah). At 1 day PP microglia were evident
in all regions of WT mice brains as shown for the thalamus
(Fig. 1Ai) and cortex (Fig. 1Be) and was consistent whether F4/80
or Iba1 immunostaining was employed (Fig. 1Ai, Be,g). In
contrast, essentially no microglia were found in Csf1r2/2 brains.
This was true whether Iba1 or F4/80 antibodies were used and
was consistent in six sections from different regions in all three
mice examined for each genotype (Fig. 1Aj, 1Bf,h). Quantifying
the entire Iba1+ cells under the microscope by manual counting of
all antibody-positive cells in one half of the D1 PP brain in coronal
sections through the optic chiasma detected less than one positive
cell per Csf1r2/2 mouse, highly significantly less than the ,350
counted in WT mice and the depletion therefore was greater than
99.7% (Fig. 1C).
Iba1 expression has been reported to be independent of
microglial activation status [42]. However, CD68 and CD45 are
markers for microglial activation and are not expressed by
microglia in normal brain [42]. Thus, to determine in the brains
of Csf1r2/2 mice whether microglia were activated with aberrant
down-regulation of Iba1, we immunostained brains of D1PP mice
with anti-CD68 and anti-CD45 antibodies. The positive controls
CSF-1R, Microglia and Olfaction
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of liver and spleen showed robust immunostaining with both
antibodies in a pattern characteristic of Kupffer cells (Fig S1e,f)
and splenic macrophages (data not shown) respectively. However,
no staining was detected in the brains of either WT mice as
expected nor in the brains of Csf1r2/2 (Figure S1a–d). Therefore
the loss of CSF-1R does not result in an aberrant activated
population of microglia that had lost Iba1 and F4/80 expression.
We can conclude therefore through the use of these four markers
that the CSF-1R is required for the presence of normal densities
and morphology of microglia in the brain from embryogenesis to
weaning.
Disruption of Brain Morphology in Csf1r Null Mutant Mice
The structural integrity of brains from 3 wk old Csf1r2/2 mice
appeared disturbed yielding more fragile specimens. However
gross morphological examination showed overall brain size was
approximately normal (Fig. 2A) and major brain regions were
present as determined using Nissl stained sections (Fig. 2B).
However, there was significant ventricular enlargement, particu-
larly notable for the lateral ventricles, with a concomitant
reduction in surrounding parenchymal volume (Fig. 2A,B). This
reduction was significant in the cerebral cortex, which was thinned
circumferentially around the ventricles (Fig. 2B,6) in an apparently
Figure 1. Loss of CSF-1R results in severe depletion of microglia. A. Coronal 5 mm sections of brains of 3 week old (a–f), E16 (g, h) and D1 PP
(i, j) mice. Wt (a, c, e, g, i) and Csf1r2/2 (b, d, f, h, j) immunostained with anti-Iba1 antibody and counterstained with hematoxylin. Sections from the
hippocampus (a, b, g, h), thalamus (c, d, i, j) and preoptic area of the hypothalamus (e,f). Bar 50 mm. B. Higher power micrographs of sections of the
thalamus (a–d, g, h), Cortex (e,f) from Wt (a, c, e, g,) and Csf1r2/2 mice (b, d, f, h,) immunostained with anti-Ibal (a–f) or anti-F4/80 (g, h) antibodies.
Mice at 3 weeks (a–d) and 1 day (e–h) of age. Brown cells in b indicate a cluster of rounded immunostained cells found in Csf1r2/2mice (b) compared
to the highly dendritic cells found in WT mice (a). c and d higher power of individual immunostained cells (arrows) showing the lack of dendritic
processes in Iba1 positive cells in Csf1r2/2 mice. a, b (Bar 20 mm), c, d, e, f, g, h (Bar 10 mm). C. Enumeration of Iba1 positive cells in a complete half
section of the brains of D1 PP WT and Csf1r2/2 (2/2) mice. N = 3/genotype. Significantly different p,0.001.
doi:10.1371/journal.pone.0026317.g001
CSF-1R, Microglia and Olfaction
PLoS ONE | www.plosone.org 3 October 2011 | Volume 6 | Issue 10 | e26317
proportional manner relative to its normal thickness. In other
words, the piriform cortex was thinner compared to the
dorsolateral cortex as it is in normal brain. Morphometric
measurements of the dorsomedial cortex approximately midway
between bregma and interaural zero along the rostro-caudal axis
indicated a ,2-fold reduction in thickness (Fig. 2E,F). The
hippocampal region while present, including CA fields, was
somewhat reduced in size and appeared distorted both mediolat-
erally and along the rostrocaudal axis (Fig. 2B5,6 and 3C,D,G,H).
Though less striking, careful examination suggested other regions
neighboring the lateral ventricles were similarly disturbed
including the amygdala and striatum (Fig. 3C–F and 3I,J). The
underlying diencenphalon was relatively unaffected (Fig. 2B5,6;
3C,D) suggesting a possible causal relationship between the
enlarged lateral ventricular space and aberrations in directly
abutting tissue. Enlargement of the cerebrospinal fluid compart-
ment extended into the olfactory ventricle (Fig. 2B1,2; 3,4) along
with a volume reduction of the surrounding olfactory area. The
olfactory bulb was consistently hollowed out in the Csf1r2/2 mice
to the point it often disintegrated during processing. Moving
caudally, prominent consistent enlargement of the 3rd or 4th
ventricles (Fig. 2B7,8) was not clear nor was an obstruction or
occlusion noted that might account for a hydrocephalic-like state.
In conjunction, the brain stem and cerebellum did not show
significant abnormalities (e.g. Fig. 2B7,8). Relevant to cerebrospi-
nal fluid regulation, choroid plexuses were generally present (e.g.
Fig. 2B6,8; 3B,D,J) and Nissl staining showed evidence of a
densely packed layer of cells lining the ventricles, consistent with
the presence of an ependymal layer (see Figs. 2B and 3).
Towards understanding the evolution of the disrupted post-
natal state, brain tissue was examined at earlier developmental
stages. At E16, the brain appeared relatively normal (Fig. 2C).
Neonatal tissue (day 1 PP) grossly showed continued normal
development but now included signs of increased lateral
ventricular size (Fig. 2D).
To examine in more detail the particularly affected regions, cell
type specific immunohistochemical stains as well as cell counts
were performed on brains from 3-week old mice. As noted above,
the cerebral cortex was notably thinned in Csf1r2/2 mice, but
closer examination of Nissl-stained sections suggested a greater
density of cells present here in the knockouts (Fig. 2E). Total cell
counts were carried out on columnar fields equal in width but
spanning the entire depth of matched dorsomedial locations of
cerebral cortex in Nissl-stained sections (as shown in Fig. 2E).
Enumeration in this way revealed no significant difference in cell
number between Csf1r2/2 and WT (Fig. 4Ba). Analogously, NeuN
staining showed increased density of neurons in Csf1r2/2 mice
(Fig. 4Aa,b) and thus no difference in total number of neurons
(Fig. 4Bb). In some thinned out cortical regions (Fig. 2B6, 2E), the
enhanced density obscured evaluation of neuronal stratification,
but neuronal layers were evident elsewhere (e.g. Fig. 3B),
suggesting migration of neuronal precursors had been largely
normal.
S100b and GFAP immunostaining to examine glial lineage cells
also both revealed an increase in density of positive cells in
cerebral cortex and hippocampus (GFAP: Fig. 4Ac–f; similar data
not shown for S100b). However, counts of total GFAP-positive
cells in cortex showed, unlike that for neurons, significantly more
are present in Csf1r2/2 than WT mice (Fig. 4Bc). The intensity of
GFAP immunostaining within individual cells also appeared
greater in knockout mice, suggesting this might represent a
reactive astrogliosis (Fig. 4Ac–f).
Immunostaining for myelin basic protein (MBP) and Nogo A
was used to evaluate differentiated myelin and oligodendrocytes,
the former being useful in evaluating the degree of relatively later
developmental events. As suggested from gross morphologic
observations based on Nissl-staining, this myelin staining presented
evidence of predominantly normal architectonics and develop-
ment (Fig. 3). For example, diencephalon and brain stem regions
examined were virtually indistinguishable in their myelinated
tracts including intact bilateral communicating pathways such as
posterior (Fig. 3A,B) and anterior commissures, local cerebral
peduncles (Fig. 3C,D) and internal capsule (Fig. 3I,J). The
striatum, although somewhat undersized, also showed grossly
typical staining patterns and more medially the internal capsule
appeared normal (Fig. 3I,J). In line with other observations,
structures immediately neighboring the lateral ventricles were the
most disturbed and the fragility of these tissues caused tearing
making precise comparisons difficult. Nevertheless, for example,
the cerebral cortical grey matter showed presence of myelinated
axons (Fig. 3A,B), and corpus callosum (Fig. 3G,H) and external
capsule (Fig. 3A,B) were evident, but in all cases these were
reduced in comparison to WT. Compatible with disturbances in
the oligodendrocyte lineage, the total number of identified Nogo1-
positive oligodendrocytes in the cerebral cortex was also reduced
by ,50% (Fig. 4Bd). Similarly, the dorsal hippocampal commis-
sure (Fig. 3G,H) and alveus of the hippocampus (Fig. 3A,B)
appeared reduced or disintegrating.
CSF-1 Deficient Mice Have Olfactory Deficits
The highly perturbed olfactory bulb in the Csf1r2/2 mice led us
to question the function of CSF-1R in olfaction. However, the lack
of viability of the Csf1r2/2 mice precluded such studies in adult
mice. We therefore turned our attention to the viable CSF-1 null
mice to determine the requirement for CSF-1 signaling in adults.
The brains of the CSF-1 ligand null mice are grossly normal and
allometrically slightly larger than WT mice [5,14,23] with none of
the obvious deficiencies described above in Csf1r2/2 mice.
Similarly, in contrast to the severe depletion of microglia in
Table 1. IBA-1 Positive cell numbers in the brains isolated
from 3 week old WT and Csf1r null mutant mice.
Region WT Csf1r
2/2
% WT
# of
sections Median
# of
sections Median
Caudate nucleusa 13 35.5 15 1.8 5.1
Thalamusa 11 19.0 15 0.2 1.1
Hypothalamusb 10 26.3 15 0.3 1.1
Hippocampus (total)a 22 28.8 28 4.0 13.9
Dentate Gyrusb 11 29.0 11 5.0 17.2
CA1c 11 28.5 17 2.5 8.8
Cortex (total)a 21 49 22 7.0 14.3
Piriform Cortexd 11 49 11 16.5 33.7
Anterior Cortexa 10 46.5 11 6.0 12.9
Totala 77 31.5 95 2.0 6.3
Cell Counts of Iba 1 positive cells in the number of sections indicated were
made in the brain regions indicated isolated from 7 WT and 8 mutant mice.
Median values are presented and percentage of wild type shown.
Csf1r 2/2 statistically different from Wild type.
ap,0.0001;
bp,0.0005;
cp,0.0002:
dp,0.05.
doi:10.1371/journal.pone.0026317.t001
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Csf1r2/2 mice as reported above, estimates for the number of
microglia in Csf1op/op mice range from no deficiency to
approximately 30% depletion [5,23,43,44,45]. These estimates
probably vary according to strain because the severity of the allele
depends upon strain background, or they may reflect develop-
mental stage or area analyzed. Nevertheless, in the strain
background used in this study there are no differences in
microglial number in adult Csf1op/op mice [5].
Measurement of the length of the olfactory bulb from rostral to
caudal in whole brains that had been carefully removed from
adult (12 weeks of age) Csf1op/op and WT mice indicated that
Csf1op/op bulbs were and ,66% (p,0.001, n = 3 for each
genotype) the length of WT bulbs (Fig. 5A), a phenotype that
was missed in earlier studies. This suggests some defect in the
development of the olfactory bulbs in the Csf1 null mice.
However, even though the size was truncated there seemed to
be no gross morphological differences between WT and mutant
mice (Fig. 5B). To measure olfaction we compared Csf1op/op with
WT adult mice in classical olfactory tests involving hidden food
challenges. Both WT and mutant mice exhibited similar sniffing
behaviors. However, the latency to find buried food was greater
in Csf1op/op versus WT mice (p,0.03; Fig. 5C, left panel), with
mutants taking 121 and 172 sec longer to find chow and cheese,
respectively. Immediately after finding food, the latency to initiate
food consumption was also measured. Csf1op/op mice took 30.8
and 12.8 sec longer (p,0.03) than WT mice to initiate
consumption of chow and cheese, respectively (Fig. 5C, right
panel). These experiments indicate that Csf1op/op mice have
olfactory deficits, consistent with a role for CSF-1R signaling in
the olfactory system.
Figure 2. Absence of CSF-1R results in perturbed brain architecture. A. Gross architecture of paraformaldehyde fixed brains from 3-week-old
mice cut 0.5 mm anterior to the optic chiasm from three WT (1–3) and three Csf1r2/2 (4–6) mice. Note the enlarged ventricles and thinned cortex in
Csf1r2/2 mice. B. 5 mm Coronal sections stained with Nissl stain. 1, 2, 3, 4, anterior olfactory nucleus. 5, 6, Cortex, thalamus and hippocampus. 7, 8,
cerebellum. 1, 3, 5, 7, WT, 2, 4, 6, 8, Csf1r2/2. Scale bar 1 mm. C. 5 mm Coronal sections stained with Nissl stain of brains from WT and Csf1r2/2 E16
mice. Bar = 500 mm. D. 5 mm Coronal section through the cortex, thalamus and hippocampus from day 1PP WT (1) and Csf1r2/2 (2) mice. Scale
bar = 1 mm. E. Close up of sections of the cortex from B5 and 6 with lines with double arrows indicating matched regions in which cell counts and
measurements were made from WT and Csf1r2/2. Bar = 200 mm. F. Cortical thickness from regions indicated in E. N= 3 for each genotype. p = 0.0168
Student’s t test.
doi:10.1371/journal.pone.0026317.g002
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CSF-1R Expressing Cells in Post-Natal Brain are Microglia
The data reported above indicate the importance of CSF-1R
in the development of microglia, maintenance of the integrity of
the brain and for olfaction. However, there has been controversy
about which brain cells express the CSF-1R other than microglia
and particularly whether neurons are able to express this protein
in a functional state [46]. Using the CSF-1R MacGreen reporter
mouse in which eGFP is expressed under the control of the Csf1r
promoter [40], Sierra et al. [37] reported that only microglia
express the CSF-1R in adult brain. To confirm and extend these
observations we used MacGreen mice to determine whether cells
other than microglia express the CSF-1R in the postnatal brain
from birth to adulthood. We systematically examined brain
regions including cerebellum, cortex, hypothalamus, striatum,
and thalamus from at least three independent mice independent
Csf1r-GFP mice per age at D1 to 17 PP and adulthood (Tables S1
and S2 for details and numbers of mice and antibodies used).
The MacGreen mouse marks all mononuclear phagocytes but
also, owing to a loss of translational control mechanism, some
neutrophils are GFP positive even though these cells don’t
express the CSF-1R protein [47]. Although neutrophils are
excluded from normal brain and are easily recognized by their
polymorphonuclear characteristics, we used anti-CSF-1R anti-
bodies [48] to validate that all GFP expressing cells were CSF-
Figure 3. Myelination patterns suggest largely normal late development but with periventricular disruption in Csf1r2/2 mice.
Coronal sections from three week old wild type (A,C,E,G,I) and Csf1r2/2 (B,D,F,H,J) mouse brain taken from equivalent co-ordinates along the
rostrocaudal axis and immunostained for myelin basic protein (MBP) by immunoperoxidase (brown) and Hematoxylin counterstained (blue).
Abbreviations: amygdale (a); alveus hippocampus (ah); cerebral cortex (c); corpus callosum (cc); cerebral peduncle (cp); dorsal hippocampal
commissure (dhc); external capsule (ec); hippocampus (h); internal capsule (ic); lateral ventricle (lv); posterior commissure (pc); striatum (s); thalamus
(t). (Section in H torn centrally during processing.) Scale bars A–F= 500 mm G–J= 200 mm.
doi:10.1371/journal.pone.0026317.g003
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1R protein positive in the brain. In all regions tested there was
100% congruence between GFP positive cells and the immuno-
staining with the anti-mouse CSF-1R antibody (Fig. 6A).
Although in thin sections as shown in the Figure 6A there
occasionally seem to be cells that do not express the receptor,
this is because the GFP is throughout the entire cell with
concentration in the nucleus whereas the receptor staining is
localized to the membrane. Z series through the labeled cells
showed complete congruence in staining (data not shown). The
congruence of CSF-1R immunostaining with the GFP expressed
from the Csf1r promoter (Fig. 6A) was true both during early
post-natal development and adult stages (shown for hypothala-
mus, Fig. 6A). These data confirm that the MacGreen mouse
strain accurately and robustly reports CSF-1R expression. Thus
MacGreen mice were used to identify CSF-1R expressing cells in
the brain.
GFP was not evident in oliogodendrocytes (identified with
MBP), astrocytes (anti-GFAP) or neurons (anti-NeuN) in any brain
area at any age examined (Fig. 6B, Table 2). Using anti-Iba1 and
anti-F4/80 [3,37] antibodies to define microglia, we found 100%
concordance of GFP with both markers in all brain regions and
ages tested (Fig. 6B and Table 2). These regions (Table S1 for
complete list) included the cerebellum, cortex, hypothalamus,
striatum, and thalamus. In some cases occasional green cells
appeared unlabeled with microglial markers when viewed in single
plane confocal sections. However, acquisition of full Z-series
optical planes showed these cells were also in fact co-labeled but
missed in single sections due to differential subcellular localization
of GFP and the antibody epitope on neighboring planes (data not
shown). Thus it can be concluded that the MacGreen mouse only
marks microglia, and during all post-natal stages and brain regions
the CSF-1R is localized exclusively to microglia.
Figure 4. Effects of the loss of the CSF-1R on cell populations in the cortex. A. 5 mm sections of cortex (a–d, g,h) and hippocampus (e, f)
immunostained with anti NeuN (a, b), anti-GFAP (c–f) or anti-Nogo A antibodies (g,h). c–h counterstained with Haematoxylin. Wild Type (a,c,e,g) and
Csf1r2/2 mice (b,d,f,h) Bar = 20 mm. B. Total cell counts (N = 3/genotype) determined as described in the materials and methods in the regions
indicated in Figure 2B 5, 6 of all Nissl stained cells (a), NeuN positive cells (b), GFAP positive cells (c) and Nogo A positive cells (d). GFAP positive cells
are increased in Csf1r2/2 mice compared to WT (p= 0.022) while Nogo A positive ones are decreased (p = 0.0314).
doi:10.1371/journal.pone.0026317.g004
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Discussion
In this report we show that normal microglia require a
functional CSF-1R for their presence in the brain during
embryogenesis, at birth and beyond weaning. The loss of CSF-
1R also produces perturbations in brain architecture. In addition
we show that CSF-1 is required for the development and/or
maintenance of normal olfaction in mice.
A major observation in this study is that in the absence of CSF-
1R there are essentially no macrophages/microglia (,99%
depletion) in the embryonic and early post-natal brain. This was
the case in all areas of the brain from embryo until day1 PP post-
partum, independent of the markers used. However at three weeks
of age while most sections examined and in almost all mice were
completely depleted of these cells within a particular brain region
there were some sections from two mice that had clusters of
positively stained cells. These cells were abnormal, being more
rounded than the WT suggesting a compromise in function or
viability. However, there was no evidence for activation of the
microglia as assessed using CD68 and CD45 markers. This mosaic
pattern of microglia in the null mutant may indicate some rescue
of the phenotype as development continues as is found in the bone
marrow and retina of Csf1op/op mice [21]. Alternatively there may
have been infiltration of Iba1 and F4/80 positive macrophages in
response to damage to the brain that was especially evident at
three weeks of age. However this hypothesis seems unlikely as
macrophages would also be expected to express CD45 while these
cells did not. Therefore overall these data suggest that there is
some compensatory post-natal development of microglia in the
absence of CSF-1R but that the cells are abnormal and unlikely to
be fully functional. In the bone of Csf1op/op mice osteoclasts,
another specialized mononuclear phagocyte, are also severely
depleted over the post-partum period giving an excluded bone
marrow cavity. However, in this tissue post-natal compensation
occurs from around four weeks of age with increased numbers of
osteoclasts developing and the bone marrow cavity being steadily
restored [49]. This compensation is due to the expression of FLT3
ligand that acts through the fms-like tyrosine kinase receptor
whose signaling circumvents CSF-1R in the osteoclast [50]. A
similar mechanism might be at play in the brain.
Macrophages are detected in the embryonic neural plate from
day 7.5 post-coitum and these cells are derived from the yolk sac
[51]. This study shows that these embryonic brain macrophages/
microglia are dependent on the CSF-1R as none are found at E16.
The same dependence on CSF-1R was found in zebrafish where
the panther mutation in the CSF1R results in a failure of the first
wave of yolk sac derived phagocytes to invade the brain [4].
However, in contrast to the zebrafish where subsequent waves of
macrophage recruitment are independent of the CSF-1R [4], this
study where overall depletion was in the order of 90% at three
week of age indicates that the CSF-1R is required at all stages of
development for recruitment and expansion of macrophages/
microglia into the brains of mice. While this paper has been under
review, Merad and co-workers using another Csf1r2/2 strain on
the FVB/NJ background also demonstrated the requirement for
CSF-1R for the presence of embryonic yolk sac macrophages and
microglia in the cortex, hippocampus and striatum during the
post-partum period to adulthood. These data together with their
lineage tracing experiments, show that yolk sac macrophages
populate the brain early in embryogenesis and then throughout life
proliferate in situ to give most if not all microglia under the
influence of the CSF-1R [52]. These data are consistent with the
data reported here and together they indicate the importance of
the CSF-1R in microglial biology.
The loss of CSF-1R also results in perturbations in brain
architecture. However, early brain development proceeds nor-
Figure 5. Olfactory Deficits in Csf1op/opmice. A. Representative gross morphology of brains of two WT mice and two Csf1op/op (op/op) mice. Note
the runting of the olfactory bulbs in Csf1op/op mice. B. Nissl stained 5 mm sections through the anterior region of olfactory bulbs of WT and Csf1op/op
mice indicate normal morphology in mutant mice. Scale bar = 1 mm. C. Olfaction tests: Mice of genotype WT (n= 9) and Csf1op/op (n = 7) as indicated
given a food finding task were challenged on the first night with chow, and on the subsequent evening with cheese. Left panel. Latency in seconds to
locate the buried food. Right panel. Latency in seconds to initiate consumption subsequent to finding food. Significant differences between
genotypes across food types p,0.03 in both panels.
doi:10.1371/journal.pone.0026317.g005
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mally with no gross defects being observed at E16 and modest
evidence of an increase in the volume of the ventricular system at
D1 PP, particularly the lateral ventricles. Ventricular enlargement
becomes more pronounced post-natally such that by 3 weeks of
age the lateral ventricles, including their anterior extension into
the olfactory bulb, are significantly enlarged and the abutting
brain regions are reduced and/or misshapen including the
cerebral cortex, olfactory bulb and hippocampus. This late
progression of pathology coincides with the time course of greatest
expansion of microglial numbers in the normal developing mouse
brain [5]. The terminal impact seen could be an outcome of
retarded development, a degenerative neurocellular state and/or a
true non-atrophic hydrocephalic condition. We favor the latter as
the likely predominant contributor given the extent of normal
development attained, including organized myelinated tracts,
evidence of sustained normal cell numbers in the markedly
thinned cerebral cortex suggesting pressure-induced compaction,
and that the brain regions most recognizably altered were
periventricular. The elevation in numbers and intensity of
GFAP-positive astrocytes would also be consistent with a reactive
response to such pathology [53,54], as well as with a degenerative
process originating in the parenchyma, but not as readily with
interrupted development. It is not clear whether the reduced
number of oligodendrocytes found in cerebral cortex are a result of
direct physical damage or of changes in this lineage, which fully
develops later than neurons and astrocytes, secondary to the
accumulating pathology in that region or to reduction of potential
trophic influences normally obtained from microglia.
This hydrocephaly may be a communicating form [55] as the
ependymal lining appears normal without obvious occlusions or
indications of obstructions of the ventricular system. If so, this
disturbed fluid regulation may indicate a minor role for microglia
and brain macrophages in vascular development [56] including
blood-brain barrier differentiation [57]. This disturbed fluid
regulation might also result from interference of normal outflow
of cerebrospinal fluid by cellular debris, especially high during
developmental programmed cell death, that would normally be
significantly cleared by phagocytic microglia in the parenchyma
[58] and by related macrophages in downstream locations such as
perivascular, ventricular, meningeal and arachnoid sites
[59,60,61].
The exact cause of the death of the Csf1r null mice is unknown
but may be related to diminishing brain function. These
neuroanatomical defects are not overtly present in the Csf1 ligand
null at least on a mixed genetic background, and these mice
generally survive for long periods [5,14,62]. This strongly suggests
that the difference in phenotype is due to IL-34 being the major
ligand for the CSF-1R in the brain. This is consistent with the high
level of IL34 expression in the brain [27]. Transgenic replacement
experiments indicate that IL-34 can compensate for CSF-1 in mice
[27]. However, cell culture experiments document differences in
signaling outputs from the two ligands [28]. These differences
together with the spatial and temporal difference in expression
[14,27,63] suggest that there will be differences in the require-
ments for these ligands in the brain. Supporting this contention is
that mice lacking CSF-1 display neurological defects manifested by
loss of normal sex steroid hormone mediated feedback in the
hypothalamus and impaired olfaction as described in this study
indicating that IL-34 cannot compensate for these functions
[5,14,33].
The viability of the Csf1op/op mice has allowed the biology of
CSF-1 to be explored. In these mice previous studies indicated a
loss of neuronal function in Csf1op/op mice confirmed by intra-
cortical electrophysiological recordings of visual evoked potentials
Figure 6. The MacGreen mouse reports CSF-1R expression in
the brain and co-localized only with microglia markers. A.
Representative 8 mm sections through the hypothalamus of the
MacGreen mouse in which GFP reports CSF-1R promoter activity (Panel
A) were immunostained with anti-mouse CSF-1R antibody labeled with
rhodamine (Panel B). Note GFP is largely cytoplasmic and nuclear while
CSF-1R is a membrane protein and therefore labels dendritic processes.
Co-localization studies were performed using confocal microscopy and
they showed complete co-incidence of labeling (merged image, panel
C). * Third Ventricle Bar = 20 mm. B. Representative coronal confocal
images of co-localization studies of 8 mm brain sections from the
MacGreen mouse in which EGFP is expressed from the Csf1r promoter
and that marks CSF-1R expressing microglia. Staining for the
rhodamine-conjugated antibodies indicated was performed as de-
scribed in the Materials and methods. Left panels Csf1r-eGFP reporter
showing GFP labeled cells, Middle panels antibody staining in red, Right
panels merged images. Antibody staining does not co-localize with
astrocyte (anti-GFAP, a–c), neuronal (anti-NeuN, d–f) or oligodendrocyte
(anti-MBP, g–i) markers. In contrast, there is complete congruence with
the microglial marker Iba1 (j–l), F480 (m–o). In some cases there
appeared to be occasional green cells that were not labeled when
viewed on single plane sections in panels g–k. However, upon optical
sectioning these were found to co-localize with the immunostain
showing that single plane images can be misleading because of
differential cellular localization of GFP and the antibody epitope (Data
not shown). A-i m,o cortex; j–l hippocampus. Bar = 20 mm.
doi:10.1371/journal.pone.0026317.g006
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(VEP) that showed that Csf1op/op mice have primary neuronal
abnormalities characterized by limited responses and dampened
recovery compared to wild type (WT) mice [14]. These data
suggested both excitatory and inhibitory defects, findings that were
confirmed by intra-cortical microinjection of the GABAA
antagonist, bicuculline [14]. This study furthered these observa-
tions of impaired brain functions by showing that Csf1op/op mice
also have diminished olfaction. Thus CSF-1 signaling is necessary
for the establishment of some neuronal circuits during develop-
ment. In support of this hypothesis is that treatment of Csf1op/op
mice with human recombinant CSF-1 during the first ten days of
life significantly reversed the defects associated with hypothalamic
functioning [5]. Furthermore, CSF-1 treatment of primary neural
cell cultures derived from the cortex, hippocampus, cerebellum
and hypothalamus of rats resulted in enhanced neuronal survival
and neurite outgrowth. Similar results were obtained in cortical
cultures from E l7 mouse brains where process outgrowth was
enhanced by addition of CSF-1 in WT but was attenuated in the
cultures derived from Csf1op/op mice [14].
The absence of CSF-1R on neurons but its expression in
microglia in post-natal mice shown in this and previous studies
[14,37] is consistent with the hypothesis that CSF-1 responsive
microglia play a role in regulating brain development. However,
caution needs to be exercised in ascribing all the CSF-1R mutant
phenotypes in the brain to loss of microglia. Firstly, microglia are
absent in mice null for the transcription factor PU.1 [64] that
regulates CSF-1R expression in macrophages [66] without reports
of brain abnormalities [65]. However, definitive conclusions on
the role of microglia in brain development cannot be drawn from
the studies of PU.1 null mice, as their early death in the immediate
postpartum period precluded further study of brain morphology.
Indeed the observations of relatively normal brain development in
PU.1 null mice are consistent with the relatively normal
development of the brains in Csf1r null mice at least until birth.
Secondly, CSF-1R expression in neurons has been reported after
brain injury [46]. This neuronal expression of the CSF-1R has
recently been confirmed in a model of kainic acid-induced
excitotoxic neurodegeneration where CSF-1R was up-regulated
in pyramidal neurons and in granule cells of the dentate gyrus. In
this model CSF-1 enhanced repair. Furthermore conditional
genetic ablation of Csf1r in neurons using CaMKIIa-cre resulted in
enhanced damage after kainic acid injury, confirming its function
in neurons (Luo et al., in review). However, our previous studies
during normal development found no evidence for CSF-1R
mRNA expression by RT-PCR of isolated neurons [14] or CSF-
1R immunostaining [5]. Likewise, the current study and that of
Sienna et al. [37] using the same reporter mouse strain found no
evidence of CSF-1R expression in any cells of the normal brain
other than microglia/macrophages in all post-natal stages and
brain regions examined. Nevertheless, it is still possible that CSF-
1R is expressed in a small sub-population of neurons or
progenitors that may not be marked by the MacGreen reporter
or in neuronal stem or progenitor cells that are most evident
during development and that would not have been observed in this
study. Alterations in the fate of progenitor cells and their
descendents might explain the altered balance between astrocytes
and oligodendrocytes found in the mutant. The relative balance of
developmental brain and behavioral defects due to lack of CSF-1
signaling in neurons and/or neural progenitors or microglia will
await differential ablation of the Csf1r in each cell type during
development.
The phenotype of Csf1op/op null mutants with their perturbed
olfaction and disrupted hypothalamic-pituitary-gondal axis is
similar to that of human patients with Kallmann’s syndrome, a
form of hypogonadotropic hypogonadism accompanied by
anosmia [67]. The association between reproductive deficits and
anosmia reflects the common embryonic origin of olfactory
receptor neurons and gonadotropin releasing hormone (GnRH)
neurons in the olfactory placode. The axons of the olfactory
receptors and the GnRH neurons must migrate through the
cribiform plate and into the olfactory bulb; GnRH neurons then
continue to migrate along the nervus terminalis to their widely
dispersed final destinations throughout the medial preoptic area.
Mutations in several different genes (e.g., KAL1, FGFR1, FGF8,
PROK2, PROK2R) result in failure of olfactory receptor axons and
GnRH neurons to transit the cribiform plate, disrupting olfactory
bulb morphogenesis and producing hypothalamic infertility
[67,68,69], reminiscent of Csf1 and Csf1r null mutants. The gross
morphological defects of the olfactory lobe in our mutant mice
resemble those of mice with a targeted null-mutation of the
prokineticin-2 gene (Prok2) [68,70]. Although this might suggest a
developmental role for microglia in the migration of GnRH
neurons out of the olfactory placode, in contrast with human
Kallmann’s syndrome patients, adult Csf1op/op mice have normal
GnRH neuron numbers and location within the preoptic area [5],
and synthesis of GnRH appears normal (Erblich and Pollard,
unpublished). Because prokineticin-2 and its receptors are also
implicated in the regulation of circadian rhythms and adult
function of GnRH neurons [69], future research might be directed
towards elucidating the developmental role of CSF-1 and CSF-1R
in establishing the afferent inputs to GnRH neurons that are
critical for their normal adult function.
In conclusion, this study demonstrates an essential role for CSF-
1R function in the development of microglia and for normal brain
Table 2. Csf1r-GFP Positive Cells Co-localize with Microglial markers.
Marker Total cells counted
Total number of
CSF-1R+ cells (green)
Total number of
antibody labeled
cells (red)
Total double
labeled cells
(yellow)
Percentage of
co-localizing cells
MBP 120 54 66 0 0%
GFAP 131 127 4 0 0%
NeuN 504 27 477 0 0%
F480 68 68 68 68 100%
Iba-1 46 46 46 46 100%
Using Z stacks of immunostained brain sections on the confocal microscope as defined in the material and methods and from regions shown in Table S1, the
coincidence of the immunostain with the GFP expressed from the Csf1r promoter was determined for the number of cells indicated in column 2.
doi:10.1371/journal.pone.0026317.t002
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architecture. In addition, we have discovered that CSF-1 is
essential to the integrity and function of the olfactory system.
These findings should open up new avenues for research to better
understand the role of CSF-1 in brain biology.
Materials and Methods
Mice
Macrophage reporter mice expressing GFP from the Csf1r
promoter (MacGreen), C57Bl/6N.Gn-Tg(Csf1r-EGFP)hume, CSF-
1R deficient, C57Bl/6N.Gn.Csf1rtmdex5jwp/tmdex5jwp (deleted in exon
5 of the Csf1r gene) hereafter referred to as Csf1r2/2 mice and
their littermate controls Csf1r+/2 and Csf1r+/+, and CSF-1 deficient
C57Bl/6N.Gn. Csf1op/op mice along with WT Csf1+/op littermates
(as controls) were bred and genotyped as described [39,40,62].
There are no reported heterozygous effects on macrophage
number or morphology by the ligand or receptor null
[18,19,21,71] and therefore these mice homozygous or heterozy-
gous for the WT allele are referred to as wild type (WT). The
Albert Einstein College of Medicine animal use protocol
committee approved all experimental procedures that were
performed in accordance to the NIH guidelines for the use and
care of mice, protocol number 20060205.
Histology and immunostaining
All mice aged 4 days and older were sedated, perfused intra-
cardially with PBS followed by 4% (w/v) paraformaldehyde
pH 7.4 made up fresh on the day of the experiment. The mice
were decapitated and their brains removed and post-fixed
overnight at 4uC in 4% (w/v) paraformaldehyde solution. E 16
and Day 1 PP mice were sedated, immediately decapitated, and
brains removed and fixed overnight in the same manner as older
mice. Brains were serially sectioned on a vibratome in the coronal
plane or paraffin sections made at 5 mm. Sections for histological
study were stained either with hematoxylin and eosin or Nissl
stain.
For immunofluorescent antibody staining 20 mm floating
sections (Table S1 for regions examined, ages and numbers of
mice) were incubated with antibodies as described in the text and
were detected with fluorescent conjugated secondary antibodies
(Table S2 for concentrations and isotypes). Following washes,
sections were stained with fluorescent Hoescht (1/10,000 dilution),
washed and mounted prior to visualization by confocal micros-
copy. At each age sections were examined serially from anterior to
posterior moving through the entire brain to assess colocalization
of antibody markers and GFP. Representative detailed images
($20 per animal) were taken of each region from the various ages
examined. Each representative image was obtained using a 406
objective; 2 mm steps were used to generate a given stack of
images. Identification of each region was achieved using the
Mouse Brain Atlas [72] as well as by examining patterns of
Hoescht staining on individual sections. All data were analyzed
using NIH Image-J software. For quantification of co-labeled cells,
counts were performed on image stacks captured on the confocal
microscope. Cells were counted manually by placing an electronic
grid over the images. Cells that intersected the grid were assigned a
count, providing a systematic scheme for quantification.
For immunohistochemistry 5 mm coronal sections of paraffin
embedded brains were incubated independently with anti-F4/80
[5], anti-ionized calcium-binding adapter molecule 1 (Iba-1), anti-
CD68, anti-CD45 (Dako, Carpinteria, CA), anti-GFAP (Santa
Cruz, CA), anti-NeuN, anti-MBP (Millipore, Billerica, MA), anti-
Nogo A (Santa Cruz, CA) antibodies, washed and specific
immunostaining detected with appropriate biotinylated secondary
antibody and an avidin-biotin/peroxidase kit (Vector Laborato-
ries, Burlingame, CA) as previously described [5]. In all cases
staining using isotype matched antibodies or immunoglobulin
from un-immunized animals did not show specific staining (not
shown). For Iba1 staining on day 21PP the following regions were
analyzed: anterior olfactory nucleus, striatum, anterior cortex/
neocortex, preoptic area of the hypothalamus, anterior commis-
sure, thalamus, hippocampus (CA1 and dentate gyrus), hypothal-
amus, 3rd ventricles, piriform cortex, fimbria, median eminence,
cerebellum, brain stem and lateral ventricles. In E16 and day 1PP
mice for microglial staining, most of the brain was examined
except for the most anterior and posterior regions.
Cell quantification of mutant and WT mice was carried out to
compare microglial numbers using Iba-1 antibody staining in
paired regions of the brain as defined in Table 1. For brain regions
containing layered architectonics (i.e., the cortex and hippocam-
pus) images were taken sequentially in a columnar manner so as to
capture all cellular layers. For other regions (e.g., thalamus and
hypothalamus) the objective was centered on the given region and
4 images were captured moving around that center point in a
clockwise direction. Control sections without primary antibody
were photographed and used to establish background thresholds
for automated counts. All digital images were taken at 2006
magnification with a CCD camera (Magnafire; Optronics) in a
color format generated by combining exposures through red, blue
and green filters. Using Metamorph image analysis software
(Molecular Devices), images were batched by region. They were
processed in an automated manner to count Iba-1 positive cell
bodies. First, the blue filter component from original RGB color
images, taken for display purposes, was isolated and converted to
monochrome for analysis. This component was selected as it
provided the greatest contrast between DAB staining and
unstained tissue, as well as the minimal detection of the blue
nuclear counterstaining performed, which could otherwise inter-
fere with Iba-1 counting. Using the ‘‘Integrated Morphometry’’
Metamorph module, Iba-1 positive cells were identified based on
pixel intensity values (threshold based on background values from
negative control sections), shape factor (roundness), and size.
Selected settings were first screened on random images to insure
cells were being accurately identified. Thus data from these
analyses included the numbers of events (positive cells), as well as
descriptive data about the morphometry of the events. Data from
the multiple images taken from each section (photographic
field = 0.1428 mm2) were averaged, yielding a count score for
each individual section. Mean and median of counts across the
multiple sections in each region were then calculated. Data on the
morphology of cells were recorded in a similar manner wherever
microglia were present. Because of the non-normal distribution of
the count data (many mutant counts were zero), non-parametric
analyses (Mann-Whitney U tests) were performed to compare the
Csf1r2/2and WT sections. For cell counts (Nissl, NeuN, Nogo A
and GFAP) in the cortex of 3-week old mice all cells were counted
through the entire depth with a defined width in the region shown
in Figure 2B5 and 6 from at least three different mice of each
genotype. At D1 PP the number of anti-Iba 1 stained cells in the
entire half of the brain from matched midsections were
enumerated from at least three mice of each genotype. Means
+/2 SD were calculated and compared by Student’s t test.
Assessment of Olfaction
To assess olfactory capabilities, Csf1op/op and WT littermates
were subjected to classic buried food challenges [73,74,75]. On the
first evening of the tests, each mouse was placed in an arena
(86 cm663 cm618 cm) for a habituation period. On the second
CSF-1R, Microglia and Olfaction
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and third evenings, mice were introduced into the test arena where
chow and cheese, respectively, were buried and given the
opportunity to find food. In the second test, the positioning of
the food cues was varied to prevent an animal from locating food
based upon memory. Time to find food and the latency to
consume was measured on each day. Data for the food-finding
olfaction study were analyzed using SAS statistical software
package version 9.1.3. A repeated measures factorial ANOVA
was employed. Mice with missing values were excluded from
analyses.
Supporting Information
Figure S1 Microglia in the Csf12/2 mice do not express
CD45 or CD68. Representative 5 mm sections of brains from wt
(a,c) and Csf1r2/2 (b, d) mice immunostained with anti-CD45 and
anti-CD68 antibodies. e, f positive controls of liver showing
Kupffer cells immunostained with anti-CD45 (e) and anti-CD68
antibodies (f). Bar = 20 mm.
(TIF)
Table S1 Brain Regions Examined for Co-Localization
of Markers on Microglia.
(DOC)
Table S2 Antibodies/Stains Working Concentrations,
Sources and Descriptions.
(DOC)
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